[PhilPhys] Call for Papers - Evidence-Based Medicine Reconsidered - University of Pittsburgh - Deadline Nov. 17

[Center for Phil Sci]

*CALL FOR PAPERS  - Deadline is November 17*



*Evidence-Based Medicine Reconsidered*


*Conference Dates: April 5-6th, 2025*

University of Pittsburgh, Pittsburgh, PA

Senior Visiting Fellow Conference by Carl Hoefer

The evidence-based medicine (EBM) movement began in the 1980s, reached its
peak perhaps in the 1990s, and has since then enjoyed the status of
orthodoxy, despite many criticisms being raised among medical practitioners
and researchers. Philosophers of medicine have frequently criticized EBM’s
hierarchies and rigid precepts, especially the “gold standard” status of
randomized controlled trials (RCTs). A pluralistic approach to evidence in
medicine has been increasingly popular in recent years, in which
mechanistic evidence and reasoning, observational studies of many kinds and
RCTs are assessed for value on a case-by-case basis. But does this trend
away from the EBM hierarchy go too far and risk the reintroduction of the
same biased, motivated evidence-gathering practices that originally
motivated the EBM movement? What light can recent experiences in medicine
and public health (e.g., during the covid-19 pandemic) shed on these issues?



Visit the website for the most up-to- date information and registration:
https://www.centerphilsci.pitt.edu/event/evidence-based-medicine-reconsidered/



*Call for Abstracts*

We invite papers which address topics related to evidence in medicine,
broadly speaking. These include, but are not limited to:

   - Defenses (or criticisms) of the supposed superiority of RCTs over
   observational studies, mechanistic studies, modeling, and individual
   clinical judgment;
   - Discussions of lessons that philosophy of medicine or EBM can learn
   from recent experiences;
   - Papers offering theoretical discussions of procedures for integrating
   and evaluating evidence from different sources;
   - The merits and limitations of emerging kinds of medical evidence, such
   as adaptive trials, so-called real-world evidence, precision or
   personalized medicine research, and big data research
   - Evidence in diverse contexts, such as clinical practice, alternative
   healthcare, drug or device regulation, public health, and health policy.



*Abstracts should be between 500-800 words long and should be sent by
November 17th to:* SVFC.2025 at gmail.com
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://listbox.elte.hu/pipermail/philphys/attachments/20241023/11a45291/attachment.html>